Immediate Impact
54 standout
Citing Papers
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
2025 Standout
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
2025 Standout
Works of Daniel Schmolze being referenced
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel Schmolze | 207 | 122 | 51 | 82 | 29 | 352 | |
| Huirong Ding | 107 | 50 | 31 | 76 | 22 | 364 | |
| Γεώργιος Αντωνίου | 137 | 169 | 13 | 40 | 31 | 359 | |
| Allan James | 157 | 74 | 85 | 34 | 29 | 410 | |
| Toshiki Kawabata | 98 | 92 | 22 | 51 | 20 | 371 | |
| Ziwei Tu | 100 | 79 | 24 | 101 | 31 | 391 | |
| Weiguo Lü | 163 | 51 | 11 | 72 | 23 | 378 | |
| Simon Schallenberg | 91 | 84 | 63 | 69 | 31 | 377 | |
| Kun Qian | 67 | 134 | 29 | 72 | 42 | 322 | |
| Jin Meng | 146 | 106 | 99 | 72 | 24 | 390 | |
| F Piccotti | 115 | 26 | 17 | 124 | 23 | 381 |
All Works
Loading papers...